Figure 2.
Impact of cytogenetics on HCT outcomes in MPN BP. Adjusted OS (A) and cumulative incidence of relapse (B) in the whole MPN-BP cohort (n = 177).

Impact of cytogenetics on HCT outcomes in MPN BP. Adjusted OS (A) and cumulative incidence of relapse (B) in the whole MPN-BP cohort (n = 177).

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal